JANUARY/FEBRUARY 2016 | Carolyn D. Runowicz, MD¹; Corinne R. Leach, PhD, MS, MPH²; N. Lynn Henny, MD, PhD³; Karen S. Henry, MSN, ARNP, FNP-BC, AOCNP⁴; Rebecca L. Cowens-Alvarado, MPH⁵; Rachel S. Cannady, BS⁶; Mandi L. Pratt-Chapman, MA⁷; Stephen B. Edge, MD, FACS⁸; Linda A. Jacobs, PhD, RN¹⁰; Arti Hurria, MD¹¹; Lawrence B. Marks, MD¹²; Samuel J. LaMonte, MD¹³; Ellen Warner, MD, FRCPC, FACP, MSc¹⁴; Gary H. Lyman, MD, MPH, FASCO, FACP¹⁵; Patricia A. Ganz, MD¹⁶
The American Cancer Society (ACS) and American Society of Clinical Oncology (ASCO) have developed a Breast Cancer Survivorship Care Guideline to assist primary care and other clinicians in the care of female adult breast cancer survivors. The guideline is based on a systematic review of the literature and expert consensus, and includes recommendations for surveillance for breast cancer recurrence, screening for second primary cancers, assessment and management of long-term and late effects of breast cancer and its treatment, health promotion, and care coordination. The guideline is intended for physicians and nurses and provides a comprehensive, holistic approach to post-treatment care. It is available for CME and CNE credit, with a maximum of 2.0 AMA PRA Category 1 Credit and 2.0 CNE credits, respectively. The activity is designed to be completed within 2.0 hours and is available for credit for 1 year following its launch date. The guideline is supported by the Centers for Disease Control and Prevention and includes disclosures of potential conflicts of interest. The authors of the guideline include experts from various disciplines, including oncology, primary care, and nursing. The guideline emphasizes the importance of addressing the unique post-treatment needs of breast cancer survivors, including the management of long-term and late effects, health promotion, and care coordination. The guideline also highlights the importance of genetic counseling and screening for second primary cancers. The recommendations are based on current evidence and expert consensus, with most of the evidence not sufficient to warrant a strong evidence-based recommendation. The guideline is intended to improve the quality of clinical follow-up care for breast cancer survivors and to provide timely and appropriate screening and surveillance to improve overall health and quality of life. The guideline is available for free CME credit and nursing contact hours through the ACS journals website.The American Cancer Society (ACS) and American Society of Clinical Oncology (ASCO) have developed a Breast Cancer Survivorship Care Guideline to assist primary care and other clinicians in the care of female adult breast cancer survivors. The guideline is based on a systematic review of the literature and expert consensus, and includes recommendations for surveillance for breast cancer recurrence, screening for second primary cancers, assessment and management of long-term and late effects of breast cancer and its treatment, health promotion, and care coordination. The guideline is intended for physicians and nurses and provides a comprehensive, holistic approach to post-treatment care. It is available for CME and CNE credit, with a maximum of 2.0 AMA PRA Category 1 Credit and 2.0 CNE credits, respectively. The activity is designed to be completed within 2.0 hours and is available for credit for 1 year following its launch date. The guideline is supported by the Centers for Disease Control and Prevention and includes disclosures of potential conflicts of interest. The authors of the guideline include experts from various disciplines, including oncology, primary care, and nursing. The guideline emphasizes the importance of addressing the unique post-treatment needs of breast cancer survivors, including the management of long-term and late effects, health promotion, and care coordination. The guideline also highlights the importance of genetic counseling and screening for second primary cancers. The recommendations are based on current evidence and expert consensus, with most of the evidence not sufficient to warrant a strong evidence-based recommendation. The guideline is intended to improve the quality of clinical follow-up care for breast cancer survivors and to provide timely and appropriate screening and surveillance to improve overall health and quality of life. The guideline is available for free CME credit and nursing contact hours through the ACS journals website.